References
- DingleKEDidelotXQuanTPEffects of control interventions on Clostridium difficile infection in England: an observational studyLancet Infect Dis201717441142128130063
- China National Health and Family Planning CommissionThe Administrative on the Clinical Use of Antimicrobial Agents and the Status Quo of Antimicrobial Resistance in ChinaBeijing, ChinaPecking Union Medical College Press2016
- ChengJWXiaoMKudinhaTThe first two Clostridium difficile ribotype 027/ST1 isolates identified in Beijing, China – an emerging problem or a neglected threat?Sci Rep201661883426740150
- WangPZhouYWangZIdentification of Clostridium difficile ribotype 027 for the first time in Mainland ChinaInfect Control Hosp Epidemiol2014351959824334809
- LessaFCMuYBambergWMBurden of Clostridium difficile infection in the United StatesN Engl J Med2015372982583425714160
- XiaoYZhangJZhengBZhaoLLiSLiLChanges in Chinese policies to promote the rational use of antibioticsPLoS Med20131011e100155624260030
- XiaoYLiLChina’s national plan to combat antimicrobial resistanceLancet Infect Dis201616111216121827788972
- QuanJLiXChenYPrevalence of mcr-1 in Escherichia coli and Klebsiella pneumoniae recovered from bloodstream infections in China: a multicentre longitudinal studyLancet Infect Dis201717440041028139430
- DonskeyCJFluoroquinolone restriction to control fluoroquinolone-resistant Clostridium difficileLancet Infect Dis201717435335428130062